MISSISSAUGA, ON, Feb. 11, 2020 /PRNewswire/ - Nuvo Pharmaceuticals
Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a
Canadian-focused healthcare company with global reach and a
diversified portfolio of commercial products, today announced it
expects to release its fourth quarter 2019 financial results before
markets open on Tuesday, February 25,
2020.
The Company will subsequently hold a conference call that same
day, Tuesday, February 25, 2020 at
8:30 a.m. ET, hosted by Jesse Ledger, Nuvo's President & Chief
Executive Officer and other senior management. A
question-and-answer session will follow the corporate update.
CONFERENCE CALL DETAILS
DATE:
|
Tuesday, February 25,
2020
|
|
|
TIME:
|
8:30 a.m.
ET
|
|
|
DIAL-IN
NUMBER:
|
416 764 8688 or 1 888
390 0546
|
|
|
TAPED
REPLAY:
|
416 764 8677 or 1 888
390 0541 / REPLAY PASSCODE: 692181 #
|
The audio webcast can be accessed at:
https://event.on24.com/wcc/r/2157012/58177B40029B0BCD961B0D0EFB9562A9
An archived replay of the webcast will be available by clicking
the link above.
About Nuvo Pharmaceuticals Inc.
Nuvo (TSX: NRI; OTCQX:
NRIFF) is a Canadian focused, healthcare company with global reach
and a diversified portfolio of commercial products. The
Company targets several therapeutic areas, including pain, allergy
and dermatology. The Company's strategy is to in-license and
acquire growth-oriented, complementary products for Canadian and
international markets. Nuvo's head office is located in
Mississauga, Ontario, Canada, the
international operations are located in Dublin, Ireland and the U.S. Food and Drug
Administration (FDA), Health Canada and E.U. approved manufacturing
facility is located in Varennes,
Québec, Canada. The Varennes
facility operates in a Good Manufacturing Practices (GMP)
environment respecting the U.S, Canada and E.U. GMP regulations and is
regularly inspected by Health Canada and the FDA. For
additional information, please visit
www.nuvopharmaceuticals.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvo-pharmaceuticals-announces-fourth-quarter-2019-results-release-date-and-conference-call-details-301002422.html
SOURCE Nuvo Pharmaceuticals Inc.